JMKX000197 not checked

Jemincare

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
2 active
3 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Malignant Pleural Effusions (Mpe) (2 trials)
Main trialPhase 2
“This study aims to evaluate the efficacy and safety of intrapleural JMKX000197 compared with intrapleural cisplatin in patients with malignant pleural effusion.”In the company’s words, NCT07649369 on ClinicalTrials.gov

Other drugs for Malignant Pleural Effusions (Mpe)

All 5 drugs for Malignant Pleural Effusions (Mpe)

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials3

TrialPhaseCompletesWhat it tests
Phase 2Not yet recruiting 12 Jan 2028 A Phase II Study to Evaluate JMKX000197 Injection Versus Cisplatin in the Treatment of Malignant Pleural Effusion
Phase 1Recruiting 31 Dec 2025 A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion
Phase 1Unknown 30 Apr 2025 A Phase I Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow JMKX000197

Following is part of Solo: you see every change to JMKX000197 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in